within Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A04A_AntiemeticsAndAntinauseants.A04AD51_ScopolamineCombinations;

model ScopolamineCombinations
  extends Pharmacolibrary.Drugs.ATC.A.A04AD51;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>A04AD51</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Scopolamine, in combination preparations, is an anticholinergic agent primarily used for the prevention of nausea and vomiting, particularly motion sickness and postoperative nausea. It has also been historically used as an adjunct in anesthesia and for gastrointestinal disorders. Approved scopolamine-containing products are in clinical use worldwide, primarily as transdermal patches.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters estimated for healthy adult subjects, as relevant data for the combination product with ATC code A04AD51 are not readily available in published literature. The estimates are based on known properties of scopolamine oral administration.</p><h4>References</h4><ol><li><p>Nachum, Z, et al., &amp; Gordon, CR (2006). Transdermal scopolamine for prevention of motion sickness : clinical pharmacokinetics and therapeutic applications. <i>Clinical pharmacokinetics</i> 45(6) 543–566. DOI:<a href=\"https://doi.org/10.2165/00003088-200645060-00001\">10.2165/00003088-200645060-00001</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/16719539/\">https://pubmed.ncbi.nlm.nih.gov/16719539</a></p></li><li><p>Nachum, Z, et al., &amp; Levy, A (2001). Scopolamine bioavailability in combined oral and transdermal delivery. <i>The Journal of pharmacology and experimental therapeutics</i> 296(1) 121–123. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/11123371/\">https://pubmed.ncbi.nlm.nih.gov/11123371</a></p></li><li><p>Putcha, L, et al., &amp; Cintrón, NM (1996). Bioavailability of intranasal scopolamine in normal subjects. <i>Journal of pharmaceutical sciences</i> 85(8) 899–902. DOI:<a href=\"https://doi.org/10.1021/js950327b\">10.1021/js950327b</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/8863287/\">https://pubmed.ncbi.nlm.nih.gov/8863287</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end ScopolamineCombinations;
